Inventor
JOHN L. GILMORE
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
C07BGeneral methods of organic chemistry9%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
12,240,840Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha202512,172,995Substituted indole and indazole compounds202411,998,537Substituted indole dimer compounds202411,878,975Substituted indole compounds useful as TLR inhibitors202411,820,7684-azaindole compounds202311,739,098Substituted indole compounds202311,701,373Substituted bicyclic compounds202311,597,721Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNa responses202311,447,466Substituted indole compounds useful as inhibitors of TLR7/8/92022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (9)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 9 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2025 |